PRO-DEX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
PRO-DEX, INC. (PDEX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $4.94 per share for the 12-month period ending 2015-06-30, per its 10-K filed 2015-09-17.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2015-11-10
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2014-09-30 was $5.58, a 137.45% increase year-over-year.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2013-09-30 was $2.35, a 69.64% decline year-over-year.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2012-09-30 was $7.74.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2015 was $4.94, a 122.52% increase from fiscal 2014.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2014 was $2.22, a 14.94% decline from fiscal 2013.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2013 was $2.61, a 8.30% increase from fiscal 2012.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2012 was $2.41.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2015-06-30 | $4.94 10-K · filed 2015-09-17 | |||
| 2015-03-31 | $4.94 10-Q · filed 2015-05-14 | |||
| 2014-12-31 | $5.58 10-Q · filed 2015-02-10 | |||
| 2014-09-30 | $5.58 10-Q · filed 2015-11-10 | |||
| 2014-06-30 | $2.22 10-K · filed 2015-09-17 | |||
| 2014-03-31 | $2.09 10-Q · filed 2015-05-14 | |||
| 2013-12-31 | $2.34 10-Q · filed 2015-02-10 | |||
| 2013-09-30 | $2.35 10-Q · filed 2014-11-13 | |||
| 2013-06-30 | $2.61 10-K · filed 2014-09-18 | |||
| 2013-03-31 | $2.35 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | $7.74 10-Q · filed 2014-02-06 | |||
| 2012-09-30 | $7.74 10-Q · filed 2013-11-13 | |||
| 2012-06-30 | $2.41 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |